Ivax Articles
IVAX confident on metformin "first-to-file"
3 November 2003
Serono beats expectations with 3rd-qtr 2003 net income up 48%
3 November 2003
IVAX confirms 3M product deal
27 October 2003
Forest/Lundbeck file suit against IVAX
29 September 2003
IVAX submits first NDA for Easi-Breathe in USA
8 September 2003
Stock Commentary - New York
18 August 2003
IVAX applies to FDA for generic Lexapro
18 August 2003
IVAX expands respiratory franchise in Europe
21 July 2003
IVAX UK plant gets $6M grant
14 July 2003
Czech Ivax opens Dubai office
23 June 2003
IVAX adds 21 generics in 15 countries
26 May 2003
IVAX wins F&S strategy award
26 May 2003
IVAX settles with Amarin over pergolide
19 May 2003
Neuro Biosci to buy stake in CLL Pharma
14 April 2003
Stock Commentary - New York
7 April 2003
IVAX names two VPs
7 April 2003
Lilly's Zyprexa faces new patent challenge
17 March 2003
IVAX seeks approval for generic Flonase
17 March 2003
IVAX gets US go-ahead for generic Nolvadex
3 March 2003
IVAX's earnings fall on lost paclitaxel sales
24 February 2003
IVAX to develop new HIV approach
10 February 2003
Serono sees 15%-20% growth for 2003
10 February 2003
IVAX also claims gabapentin exclusivity
10 February 2003
IVAX gets US OK for generic Relafen
3 February 2003
IVAX Diagnostics' share repurchase
13 January 2003
IVAX Pharmaceuticals UK 's new managing director
5 August 2002
IVAX tentative FDA alendronate approval
5 August 2002
Stock Commentary - New York
15 July 2002
First approvals for generic Axid in USA
15 July 2002
French generics sales up on govt/doc deal
15 July 2002
Italy
15 July 2002
IVAX remains confident on its prospects
15 July 2002
IVAX' Salamol OKed in Germany
8 July 2002
IVAX wins generic approvals in Poland
8 July 2002
IVAX Labs appointments
24 June 2002
IVAX ' QVAR OKed for US pediatric use
20 May 2002
Appointments at IVAX
13 May 2002
Stock Commentary - New York
13 May 2002
Abbott, NaPro get OK for generic Taxol in USA
13 May 2002
IVAX gets tentative OK for generic Neurontin
13 May 2002
Stock Commentary - New York
15 April 2002
UK generics firms raided by SFO
15 April 2002
IVAX to initiate Ph II trial of BNP-166 in Crohn's
1 April 2002
IVAX buys intranasals from Roche
1 April 2002
IVAX increases repurchase program
25 March 2002
IVAX UK appointments
4 February 2002
IVAX' paclitaxel gets ok to stay on US market
4 February 2002
Glucophage generics arrive on US market
4 February 2002
Stock Commentary - New York.
21 January 2002
IVAX ripe for takeover?
21 January 2002
IVAX welcomes Ca court decision on AB Taxol-related patents.
21 January 2002
SPECTRUM.
21 January 2002
IVAX' talampanel found to be neuroprotective
13 December 2001
Slovakofarma to be taken over by Leciva?
11 December 2001
Stock Commentary - New York
6 December 2001
Stock Commentary - New York
29 November 2001
Update: Glucophage generic gets initial OK in USA
26 November 2001
IVAX gets initial OK for generic metformin in USA
23 November 2001
Bristol-Myers Squibb highlights five key products at R&D day
15 November 2001
Elan and Vernalis antimigraine drug wins US approval
12 November 2001
Stock Commentary - New York
8 November 2001
IVAX to make doxycycline as anthrax treatment in USA
6 November 2001
Czech Ivax-CR seeks higher exports
30 October 2001
IVAX profits leap, but Onxol disappoints
29 October 2001
IVAX reports progress with oral paclitaxel
23 October 2001
Stock Commentary - New York
4 October 2001
US states sue Abbott, Geneva and IVAX
2 October 2001
Stock Commentary - New York
27 September 2001
IVAX acquires intranasals from Elan
26 September 2001
IVAX Corp completes acquisition of LabChile
19 September 2001
Generics industry poised for gold rush as blockbusters lose protection
13 September 2001
Cipla signs deal with IVAX affiliate
5 September 2001
Appointments at IVAX
30 August 2001
IVAX' oral paclitaxel shows promise in Ph II
6 August 2001
Stock Commentary - New York
2 August 2001
Stock Commentary - New York
1 August 2001
Stock Commentary - New York
21 June 2001
Unprecedented growth forecast for generics
18 June 2001
IVAX to begin GYKI-16084 Phase II study
12 June 2001
Stock Commentary - New York
7 June 2001
180-day exclusivity for Teva's famotidine
6 June 2001
IVAX-CR forecasting strong profit growth
24 May 2001
Stock Commentary - New York
10 May 2001
IVAX offering up to $500M in senior notes
1 May 2001
IVAX Corp boosted by court decision
23 April 2001
Generics firms take on Merck & Co's Pepcid
17 April 2001
Cipla mulls felodipine deal with Mutual
10 April 2001
IVAX buyback update
10 April 2001
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Is failure to adopt business process management putting the pharma industry at risk?
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
